Adam C. Vandervoort Sells 5,500 Shares of Teladoc Health Inc (TDOC) Stock

Teladoc Health Inc (NYSE:TDOC) insider Adam C. Vandervoort sold 5,500 shares of the company’s stock in a transaction dated Tuesday, January 8th. The shares were sold at an average price of $53.80, for a total transaction of $295,900.00. Following the sale, the insider now owns 2,934 shares of the company’s stock, valued at $157,849.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Shares of Teladoc Health stock opened at $55.47 on Friday. The company has a current ratio of 8.99, a quick ratio of 8.99 and a debt-to-equity ratio of 0.40. The stock has a market cap of $3.86 billion, a price-to-earnings ratio of -33.62 and a beta of 1.21. Teladoc Health Inc has a 1-year low of $30.88 and a 1-year high of $89.05.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings data on Thursday, November 1st. The health services provider reported ($0.34) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.36) by $0.02. The firm had revenue of $111.00 million for the quarter, compared to analysts’ expectations of $109.94 million. Teladoc Health had a negative net margin of 31.32% and a negative return on equity of 14.05%. The company’s quarterly revenue was up 61.6% compared to the same quarter last year. During the same period in the prior year, the firm earned ($0.55) earnings per share. As a group, equities analysts anticipate that Teladoc Health Inc will post -1.48 EPS for the current year.

A number of institutional investors have recently modified their holdings of the business. Retirement Systems of Alabama grew its stake in Teladoc Health by 76.1% during the fourth quarter. Retirement Systems of Alabama now owns 70,800 shares of the health services provider’s stock worth $3,510,000 after buying an additional 30,600 shares during the last quarter. Vanguard Group Inc grew its stake in shares of Teladoc Health by 26.9% during the third quarter. Vanguard Group Inc now owns 5,874,182 shares of the health services provider’s stock valued at $507,236,000 after purchasing an additional 1,244,388 shares during the last quarter. Federated Investors Inc. PA bought a new stake in shares of Teladoc Health during the third quarter valued at approximately $3,021,000. Marshall Wace North America L.P. grew its stake in shares of Teladoc Health by 313.5% during the third quarter. Marshall Wace North America L.P. now owns 202,001 shares of the health services provider’s stock valued at $17,443,000 after purchasing an additional 153,146 shares during the last quarter. Finally, Reynders McVeigh Capital Management LLC grew its stake in shares of Teladoc Health by 2.8% during the third quarter. Reynders McVeigh Capital Management LLC now owns 145,529 shares of the health services provider’s stock valued at $12,566,000 after purchasing an additional 3,930 shares during the last quarter.

A number of research firms have issued reports on TDOC. upped their price target on shares of Teladoc Health from $68.00 to $89.00 and gave the company an “outperform” rating in a report on Friday, September 28th. Robert W. Baird upped their price target on shares of Teladoc Health from $65.00 to $80.00 and gave the company a “neutral” rating in a report on Friday, September 28th. Citigroup restated a “buy” rating and set a $95.00 price target on shares of Teladoc Health in a report on Friday, September 28th. Cantor Fitzgerald upped their price target on shares of Teladoc Health from $52.00 to $83.00 and gave the company a “neutral” rating in a report on Friday, September 28th. They noted that the move was a valuation call. Finally, KeyCorp upped their price target on shares of Teladoc Health from $90.00 to $94.00 and gave the company an “overweight” rating in a report on Friday, September 28th. Five analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus target price of $83.42.

WARNING: This article was originally published by Transcript Daily and is owned by of Transcript Daily. If you are reading this article on another publication, it was copied illegally and reposted in violation of United States & international copyright and trademark legislation. The legal version of this article can be viewed at https://transcriptdaily.com/2019/01/12/adam-c-vandervoort-sells-5500-shares-of-teladoc-health-inc-tdoc-stock.html.

Teladoc Health Company Profile

Teladoc Health, Inc provides telehealth services worldwide. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

Featured Article: Risk Tolerance and Your Investment Decisions

Insider Buying and Selling by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply